These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 3918397

  • 1. Plasma growth hormone (GH) responses to single and repetitive subcutaneous administration of GH releasing factor (hpGRF-44) in normal and GH deficient children.
    Takano K, Hizuka N, Shizume K, Honda N, Ling NC.
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):11-9. PubMed ID: 3918397
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Plasma growth hormone responses to repetitive administrations of growth hormone releasing factor in patients with pituitary dwarfism.
    Hizuka N, Takano K, Shizume K, Hirose N, Ling NC.
    Endocrinol Jpn; 1984 Dec; 31(6):697-704. PubMed ID: 6442698
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Plasma growth hormone (GH) response to GH-releasing factor in normal children with short stature and patients with pituitary dwarfism.
    Takano K, Hizuka N, Shizume K, Asakawa K, Miyakawa M, Hirose N, Shibasaki T, Ling NC.
    J Clin Endocrinol Metab; 1984 Feb; 58(2):236-41. PubMed ID: 6420432
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man.
    Vance ML, Borges JL, Kaiser DL, Evans WS, Furlanetto R, Thominet JL, Frohman LA, Rogol AD, MacLeod RM, Bloom S.
    J Clin Endocrinol Metab; 1984 May; 58(5):838-44. PubMed ID: 6423660
    [Abstract] [Full Text] [Related]

  • 11. Idiopathic growth hormone (GH) deficiency, and GH deficiency secondary to hypothalamic germinoma: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid.
    Chihara K, Kashio Y, Abe H, Minamitani N, Kaji H, Kita T, Fujita T.
    J Clin Endocrinol Metab; 1985 Feb; 60(2):269-78. PubMed ID: 3917456
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature.
    Rogol AD, Blizzard RM, Johanson AJ, Furlanetto RW, Evans WS, Rivier J, Vale WW, Thorner MO.
    J Clin Endocrinol Metab; 1984 Oct; 59(4):580-6. PubMed ID: 6434572
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The effect of synthetic human pancreatic growth hormone-releasing factor (hpGRF-44) on serum growth hormone response in normal and obese subjects].
    Shimizu T, Inoue K.
    Nihon Naibunpi Gakkai Zasshi; 1986 Feb 20; 62(2):82-96. PubMed ID: 3084310
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.